These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15944807)

  • 1. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
    Bullard AJ; Govewalla P; Yellon DM
    Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
    Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
    Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
    Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
    Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin limits reperfusion injury in experimental myocardial infarction.
    Hamid SA; Baxter GF
    Basic Res Cardiol; 2005 Sep; 100(5):387-96. PubMed ID: 16010601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
    J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.
    Shan X; Xu X; Cao B; Wang Y; Guo L; Zhu Q; Li J; Que L; Chen Q; Ha T; Li C; Li Y
    Int J Cardiol; 2009 May; 134(3):384-92. PubMed ID: 18672303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
    Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
    FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway.
    Rajesh KG; Suzuki R; Maeda H; Yamamoto M; Yutong X; Sasaguri S
    J Mol Cell Cardiol; 2005 Nov; 39(5):766-76. PubMed ID: 16171810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase.
    Kleinz MJ; Baxter GF
    Regul Pept; 2008 Feb; 146(1-3):271-7. PubMed ID: 18022257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.